Phase 4 Reflux Disease Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole
Gastroesophageal Reflux Disease
Carnot Laboratories128 enrolled2 locationsNCT06991348
Recruiting
Phase 4
Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease
Gastroesophageal Reflux Disease (GERD)
Tanta University44 enrolled1 locationNCT06564246
Completed
Phase 4
The Rabeprazole and Esomeprazole Reflux Assessment Trial
Gastro-oesophageal reflux disease
Janssen-Cilag Pty Ltd1,908 enrolled1 locationACTRN12607000006448